HIKMA Pharmaceuticals PLC — Director's Dealing 2017

Apr 13, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4403C

Hikma Pharmaceuticals Plc

13 April 2017

Notification and public disclosure of transactions by persons discharging managerial responsibilities

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Michael Raya

2

Reason for the notification

a)

Position/status

CEO of West-Ward Pharmaceuticals

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

Further Shares disposed from vesting of the conditional awards on 10 April 2017 under the 2014 Executive Incentive Plan (EIP). An additional 2,370 shares were sold to cover tax and associated costs resulting in 9,383 shares being retained.

c)

Price(s) and volume(s)

Price	Volume(s)
£19.42	2,370
£0.00	9,383

d)

Aggregated information

£19.42

£46,025

e)

Date of the transaction

12 April 2017

f)

Place of the transaction

London Stock Exchange (XLON)

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHGRGDSLUBBGRX